Low-dose aripiprazole in the treatment of selective serotonin reuptake inhibitors-induced orofacial and buccal dystonia

Psychiatry and Clinical Neurosciences

Volumn 66, Issue 5, 2012, Pages 462-463

  Oulis, Panagiotis ^a   Konstantakopoulos, George ^a   Nathanailidis, Euthymios ^a   Tsiamoura, Magdalini ^a   Kollias, Konstantinos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; PAROXETINE;

ADULT; AGORAPHOBIA; BUCCAL DYSTONIA; CASE REPORT; COGNITIVE THERAPY; DRUG INDUCED DISEASE; DYSTONIA; FEMALE; FOLLOW UP; HUMAN; LETTER; LOW DRUG DOSE; MEDICAL HISTORY; MOTOR ACTIVITY; MUSCLE CONTRACTION; OROFACIAL DYSTONIA; TREATMENT OUTCOME;

ADULT; AGORAPHOBIA; ANTIPSYCHOTIC AGENTS; DYSTONIA; FACE; FEMALE; HUMANS; PANIC DISORDER; PAROXETINE; PIPERAZINES; QUINOLONES; SEROTONIN UPTAKE INHIBITORS;

EID: 84864416720     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2012.02363.x     Document Type: Letter

References (3)

1. Gerber PE, Lynd LD,. Selective serotonin-reuptake inhibitor-induced movement disorders. Ann. Pharmacother. 1998; 32: 692-698.
2. Bostwick JM, Jaffee MS,. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. J. Clin. Psychiatry 1999; 60: 857-860.
3. Kishi Y,. Paroxetine-induced bruxism effectively treated with tandospirone. J. Neuropsychiatry Clin. Neurosci. 2009; 19: 90-91. (Pubitemid 46294458)